Page 45 - Read Online

Kondapuram et al. J Cancer Metastasis Treat 2019;5:32 I http://dx.doi.org/10.20517/2394-4722.2018.105 Page 23 of 25

44. Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci 2018;19:3466.
45. Koustas E, Papavassiliou AG, Karamouzis MV. The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs
based on microsatellite instability status. PLoS One 2018;13:e0207227.
46. Boutouja F, Brinkmeier R, Mastalski T, Magraoui F, Platta HW. Regulation of the tumor-suppressor beclin 1 by distinct ubiquitination
cascades. Int J Mol Sci 2017;18:E2541.
47. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, et al. Protein and mRNA expression of autophagy gene beclin 1 in human brain
tumours. Int J Oncol 2007;30:429-36.
48. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011;10:1533-41.
49. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and
ATGI2 in gastric and colorectal cancers with microsatellite instability. J Pathol 2009;217:702-6.
50. Lipinski MM, Hoffman G, Ng A, Zhou W, Py BF, et al. A genome-wide siRNA screen reveals multiple mTORC1 independent signaling
pathways regulating autophagy under normal nutritional conditions. Dev Cell 2010;18:1041-52.
51. Tang F, Hu P, Yang Z, Xue C, Gong J, et al. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by
modulating both autophagy and apoptosis pathways. Oncol Rep 2017;37:3449-58.
52. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor
induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009;29:2570-81.
53. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008;9:517-31.
54. Ahn JH, Lee M. Autophagy-dependent survival of mutant B-Raf melanoma cells selected for resistance to apoptosis induced by inhibitors
against oncogenic B-Raf. Biomol Ther 2013;21:114-20.
55. Russo M, Russo GL. Autophagy inducers in cancer. Biochem Pharmacol 2018;153:51-61.
56. He S, Li Q, Jiang X, Lu X, Feng F, et al. Design of small molecule autophagy modulators: a promising druggable strategy. J Med Chem
2018;61:4656-87.
57. Kwitkowski VE, Prowell TM, Ibrahim A, Farrell AT, Justice R, et al. FDA approval summary: temsirolimus as treatment for advanced
renal cell carcinoma. Oncologist 2010;15:428-35.
58. Koschmann C, Farooqui Z, Kasaian K, Cao X, Zamler D, et al. Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes
PTEN loss as an early event. NPJ Precis Oncol 2017;1:32.
59. Klionsky DJ, Eskelinen EL, Deretic V. Autophagosomes, phagosomes, autolysosomes, phagolysosomes, autophagolysosomes… wait, I’m
confused. Autophagy 2014;10:549-51.
60. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, Pirola L, Vanhaesebroeck B. Wortmannin inactivates phosphoinositide 3-Kinase by
covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 1996;16:1722-33.
61. McNamara CR, Degterev A. Small-molecule inhibitors of the PI3K signaling network. Future Med Chem 2011;3:549-65.
62. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, et al. Exploring the specificity of the PI3K family inhibitor LY294002.
Biochem J 2007;404:15-21.
63. Harding JJ, Bauer TM, Tan DSW, Bedard PL, Rodon J, et al. Characterization and phase I study of CLR457, an orally bioavailable pan-
class I PI3-kinase inhibitor. Invest New Drugs 2019;37:271-81.
64. Knight SD, Adams ND, Burgess JL, Chaudhari AM, Darcy MG, et al. Discovery of GSK2126458, a highly potent inhibitor of PI3K and
the mammalian target of rapamycin. ACS Med Chem Lett 2010;1:39-43.
65. Basu D, Salgado CM, Bauer B, Khakoo Y, Patel JR, et al. The dual PI3K/mToR inhibitor omipalisib/GSK2126458 inhibits clonogenic
growth in oncogenically-transformed cells from neurocutaneous melanocytosis. Cancer Genomics and Proteomics 2018;15:239-48.
66. Liu Q, Xu C, Kirubakaran S, Zhang X, Hur W, et al. Characterization of torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR.
Cancer Res 2013;73:2574-86.
67. Nelson EE, Guyer AE. The development of the ventral prefrontal cortex and social flexibility. Dev Cogn Neurosci 2011;1:233-45.
68. Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive
mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 2010;70:288-98.
69. Wang L, Zhu YR, Wang S, Zhao S. Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo.
Tumor Biol 2016;37:11743-52.
70. Park S, Chapuis N, Bardet V, Tamburini J, Gallay N, et al. PI-103, a dual inhibitor of class IA phosphatidylinositide 3-kinase and mTOR,
has antileukemic activity in AML. Leukemia 2008;22:1698-706.
71. Mallon R, Feldberg LR, Lucas J, Chaudhary I, Dehnhardt C, et al. Antitumor efficacy of PKI-587, a highly potent dual PI3K/mTOR
kinase inhibitor. Clin Cancer Res 2011;17:3193-203.
72. Powles T, Lackner MR, Oudard S, Escudier B, Ralph C, et al. Randomized open-label phase II trial of apitolisib (GDC-0980), a novel
inhibitor of the PI3K/mammalian target of rapamycin pathway, versus everolimus in patients with metastatic renal cell carcinoma. J Clin
Oncol 2016;34:1660-8.
73. Simioni C, Cani A, Martelli AM, Zauli G, Alameen AA, et al. The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic
activity in both normoxic and hypoxic hepatocarcinoma cells. Oncotarget 2015;6:17147-60.
74. Li H, Jin X, Zhang Z, Xing Y, Kong X. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-
BEZ235 in renal cell carcinoma cells. Cell Biochem Funct 2013;31:427-33.
75. Lazarus MB, Novotny CJ, Shokat KM. Structure of the human autophagy initiating kinase ULK1 in complex with potent inhibitors. ACS
Chem Biol 2015;10:257-61.
76. Martin KR, Celano SL, Solitro AR, Gunaydin H, Scott M, et al. A potent and selective ULK1 inhibitor suppresses autophagy and
sensitizes cancer cells to nutrient stress. iScience 2018;8:74-84.
77. Limpert AS, Lambert LJ, Bakas NA, Bata N, Brun SN, et al. Autophagy in cancer: regulation by small molecules. Trends Pharmacol Sci
2018;39:53-63.